Bentham Science Logo
Track your manuscript:


Scopus CiteScore Metrics: 1.84

Browse Contents
Select Volume:  

Select Issue:  

Select Article:


Abstracted/Indexed in




Endorsements

"The new journal on Recent Patents on Anti-Cancer Drug Discovery is an important patent journal in the field of Anti-Cancer Drug Discovery, which should provide research scientists in the field with recent developments in various frontier areas. The journal is strongly recommended to the scientific community."

Robert Huber
Nobel Laureate

Forthcoming Special Issues
Please visit again after some time to view these Issues.
Special Issues - In-Press
Please visit again after some time to view these Issues.
Published Special Issues
Please visit again after some time to view these Issues.
Authors' Comments
Working with you was a great experience. Thank you for your service

Zahra Shaghaghi
(Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran)


Recent Patents on Anti-Cancer Drug Discovery

,

Volume 13

-

Number 4



Biography   Open Access



Review Article

PARP Inhibitors in Ovarian Cancer

, 13(4): 392 - 410

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*


DOI: 10.2174/1574892813666180305165256


Review Article

Journey Describing the Cytotoxic Potential of Withanolides: A Patent Review

, 13(4): 411 - 421

Hidayat Hussain*, Rene Csuk, Ivan R. Green, Najeeb Ur Rehman, Ghulam Abbas and Wahid Hussain


DOI: 10.2174/1574892813666180808154928


Review Article   Open Access



Review Article   Open Access



Review Article

Recent Progress of Marine Polypeptides as Anticancer Agents

, 13(4): 445 - 454

Lanhong Zheng, Yixin Xu, Xiukun Lin*, Zhixin Yuan, Minghua Liu, Shousong Cao, Fuming Zhang and Robert J. Linhardt


DOI: 10.2174/1574892813666180430110033


Review Article



Semi-Synthetic Derivatives of Heliomycin with an Antiproliferative Potency

, 13(4): 469 - 472

Georgy Y. Nadysev, Alexander S. Tikhomirov, Lyubov G. Dezhenkova and Andrey E. Shchekotikhin*


DOI: 10.2174/1574892813666180723150542


Articles Ahead of Print

Cucurbitacins as Anticancer Agents: A Patent Review


Hidayat Hussain*, Ivan R. Green, Muhammad Saleem, Khanzadi Fatima Khattak, Muhammad Irshad and Maroof Ali


View Abstract View on PubMed




Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents An Increasing Interest in Nanoparticles in Cancer


Maricruz Anaya-Ruiz, Cindy Bandala, Gerardo Landeta, Patricia Martínez-Morales, Jose Lino Zumaquero-Rios, Jorge Sarracent-Pérez and Martin Perez-Santos*


View Abstract View on PubMed


Abstracts Ahead of Print

There are currently no Abstracts Ahead of Print available for this journal.

Editor's Choice

PARP Inhibitors in Ovarian Cancer

, 2018; 13(4): 392 - 410

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*


DOI: 10.2174/1574892813666180305165256







Pharmacological Inhibitors of NAD Biosynthesis as Potential An ticancer Agents

, 2017; 12(3): 190 - 207

Stephanie Lucas, Claire Soave, Ghazal Nabil, Zainab Sabry Othman Ahmed, Guohua Chen, Hossny Awad El-Banna, Q. Ping Dou* and Jian Wang*


DOI: 10.2174/1574892812666170619125503





Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent

, 2017; 12(2): 174 - 185

Shirin Mollazadeh, Jamal Shamsara, Maryam Iman* and Farzin Hadizadeh*


DOI: 10.2174/1574892812666170126162521



Kinase Inhibitor Indole Derivatives as Anticancer Agents: A Patent Review

, 2017; 12(1): 55 - 72

Anuj K. Rathi, Riyaz Syed, Vijay Singh, Han-Seung Shin and Rahul V. Patel


DOI: 10.2174/1574892811666161003112119



Open Access Articles

Semi-Synthetic Derivatives of Heliomycin with an Antiproliferative Potency

, 2018; 13(4): 469 - 472

Georgy Y. Nadysev, Alexander S. Tikhomirov, Lyubov G. Dezhenkova and Andrey E. Shchekotikhin*





Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature

, 2018; 13(4): 422 - 427

Sara Petrillo, Emanuela Tolosano, Luca Munaron and Tullio Genova*




PARP Inhibitors in Ovarian Cancer

, 2018; 13(4): 392 - 410

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*





Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options

, 2018; 13(2): 209 - 223

Theodosis Kalamatianos, Despoina Denekou, George Stranjalis and Evangelia Papadimitriou*




Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied

, 2018; 13(2): 201 - 208

Silvia M. Ferrari, Ilaria Ruffilli, Marco Centanni, Camilla Virili, Gabriele Materazzi, Magdalini Alexopoulou, Mario Miccoli, Alessandro Antonelli* and Poupak Fallahi




Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184 - 200

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*




PARP Inhibitors in Epithelial Ovarian Cancer

, 2018; 13(2): 145 - 158

Kristin N. Taylor and Ramez N. Eskander*





Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy

, 2018; 13(1): 86 - 105

Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*




Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy

, 2018; 13(1): 2 - 17

Sandra Iurescia*, Daniela Fioretti and Monica Rinaldi*




Strategies to Tackle Radiation Resistance by Penetrating Cancer Stem Cell Line of Scrimmage

, 2018; 13(1): 18 - 39

So-Yeon Park, Ji-Young Kim, Youngsoo Jun and Jeong-Seok Nam*







Most Cited Articles

Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far

, 2016; 11(1): 67-97.

Devivasha Bordoloi, Nand K. Roy, Javadi Monisha, Ganesan Padmavathi and Ajaikumar B. Kunnumakkara


DOI: 10.2174/1574892810666151020101706


Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment

, 2016; 11(2): 184-196.

Li Huang, Rongzhang He, Weihao Luo, Yuan-Shan Zhu, Jia Li, Tan Tan, Xi Zhang, Zheng Hu and Dixian Luo


DOI: 10.2174/1574892811888160304113346



Saffron-Based Crocin Prevents Early Lesions of Liver Cancer: In vivo, In vitro and Network Analyses

, 2016; 11(1): 121-133.

Amr Amin, Alaaeldin A. Hamza, Sayel Daoud, Kamal Khazanehdari, Ala’a Al Hrout, Badriya Baig, Amphun Chaiboonchoe, Thomas E. Adrian, Nazar Zaki and Kourosh Salehi-Ashtiani


DOI: 10.2174/1574892810666151102110248


Decreased Expression of Caveolin-1 and E-Cadherin Correlates with the Clinicopathologic Features of Gastric Cancer and the EMT Process

, 2016; 11(2): 236-244.

Kundong Zhang, Guang Yang, Weidong Wu, Jing Zhang, Xiang Xia, Tao Jiang, Jun Cao, Kejan Huang, Zhengjun Qiu and Chen Huang


DOI: 10.2174/1574892811666160128151437




Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells

, 2016; 11(2): 215-227.

Yanming Wang, Jun Ma, Xinyan Yan, Xiaoyu Chen, Lingling Si, Ying Liu, Jichun Han, Wenjin Hao and Qiusheng Zheng


DOI: 10.2174/1573406412666160307151904


Epigenetics in Medullary Thyroid Cancer: From Pathogenesis to Targeted Therapy

, 2016; 11(3): 275-282.

Giovanni Vitale, Alessandra Dicitore, Erika Messina, Concetta Sciammarella, Antongiulio Faggiano and Annamaria Colao


DOI: 10.2174/1574892811666160614115356


Anti-EGFR Therapy: Strategies in Head and Neck Squamous Cell Carcinoma

, 2016; 11(2): 170-183.

Renato J. Oliveira-Silva, Ana Carolina de Carvalho, Luciano de Souza Viana, Andre L. Carvalho and Rui M. Reis


DOI: 10.2174/1574892811666160309121238



Most Accessed Articles


Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy

, 2018; 13(1): 86-105.

Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*


DOI: 10.2174/1574892812666171108124218



Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184-200.

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*


DOI: 10.2174/1574892812666171129141211






PARP Inhibitors in Ovarian Cancer

, 2018; 13(4): 392-410.

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*


DOI: 10.2174/1574892813666180305165256




Webmaster Contact: info@benthamscience.net
Copyright © 2018 Bentham Science | Privacy Policy